Hoppensteadt D - Search Results

1

High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.

Erez O, Romero R, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Chaiworapongsa T, Gotsch F, Fareed J, Hoppensteadt D, Than NG, Yoon BH, Edwin S, Dong Z, Espinoza J, Mazor M, Hassan SS. Erez O, et al. Among authors: hoppensteadt d. J Matern Fetal Neonatal Med. 2010 Jan;23(1):23-33. doi: 10.3109/14767050902994770. J Matern Fetal Neonatal Med. 2010. PMID: 19883261 Free PMC article.

2

Laboratory monitoring of the clinical effects of low molecular weight heparins.

Walenga JM, Hoppensteadt D, Fareed J. Walenga JM, et al. Among authors: hoppensteadt d. Thromb Res Suppl. 1991;14:49-62. doi: 10.1016/0049-3848(91)90403-j. Thromb Res Suppl. 1991. PMID: 1658970 Clinical Trial.

3

Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.

Ofosu FA, Fareed J, Smith LM, Anvari N, Hoppensteadt D, Blajchman MA. Ofosu FA, et al. Among authors: hoppensteadt d. Eur J Biochem. 1992 Jan 15;203(1-2):121-5. doi: 10.1111/j.1432-1033.1992.tb19836.x. Eur J Biochem. 1992. PMID: 1730217 Free article.

4

Laboratory assays for the evaluation of recombinant hirudin.

Walenga JM, Hoppensteadt D, Koza M, Wallock M, Pifarre R, Fareed J. Walenga JM, et al. Among authors: hoppensteadt d. Haemostasis. 1991;21 Suppl 1:49-63. doi: 10.1159/000216263. Haemostasis. 1991. PMID: 1894197

5

Modifications of plasma levels of tissue factor pathway inhibitor and endothelin-1 induced by a reverse Trendelenburg position: influence of elastic compression--preliminary results.

Arcelus JI, Caprini JA, Hoffman KN, Traverso CI, Hoppensteadt D, Fareed J. Arcelus JI, et al. Among authors: hoppensteadt d. J Vasc Surg. 1995 Nov;22(5):568-72. doi: 10.1016/s0741-5214(95)70039-0. J Vasc Surg. 1995. PMID: 7494357 Free article.

6

Effect of repeated Aprosulate and Enoxaparin administration on tissue factor pathway inhibitor antigen levels.

Jeske W, Hoppensteadt D, Klauser R, Kammereit A, Eckenberger P, Haas S, Wyld P, Fareed J. Jeske W, et al. Among authors: hoppensteadt d. Blood Coagul Fibrinolysis. 1995 Apr;6(2):119-24. doi: 10.1097/00001721-199504000-00005. Blood Coagul Fibrinolysis. 1995. PMID: 7605876 Clinical Trial.

7

Tissue factor antigen levels in various biological fluids.

Fareed J, Callas DD, Hoppensteadt D, Bermes EW Jr. Fareed J, et al. Among authors: hoppensteadt d. Blood Coagul Fibrinolysis. 1995 Jun;6 Suppl 1:S32-6. doi: 10.1097/00001721-199506001-00006. Blood Coagul Fibrinolysis. 1995. PMID: 7647218

8

Measurement of functional and immunologic levels of tissue factor pathway inhibitor. Some methodologic considerations.

Jeske W, Hoppensteadt D, Fareed J, Bermes E. Jeske W, et al. Among authors: hoppensteadt d. Blood Coagul Fibrinolysis. 1995 Jun;6 Suppl 1:S73-80. doi: 10.1097/00001721-199506001-00012. Blood Coagul Fibrinolysis. 1995. PMID: 7647226

9

Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin.

Callas DD, Hoppensteadt D, Fareed J. Callas DD, et al. Among authors: hoppensteadt d. Semin Thromb Hemost. 1995;21(2):177-83. doi: 10.1055/s-2007-1000393. Semin Thromb Hemost. 1995. PMID: 7660140

10

Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins.

Jeske W, Lormeau JC, Callas D, Iqbal O, Hoppensteadt D, Fareed J. Jeske W, et al. Among authors: hoppensteadt d. Semin Thromb Hemost. 1995;21(2):193-200. doi: 10.1055/s-2007-1000395. Semin Thromb Hemost. 1995. PMID: 7660142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters